Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

Clinical trial NCT00295061 · COMPLETED

Trial details

NCT number: NCT00295061
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2006-05-01
Primary completion: 2007-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.